Search research articles
Contact Us
Filters
Showing results (551-560 of 586) with videos related to
Page
of 59
Sort By:
Neurology
|
May 14, 2008
Cognitive and psychosocial features of childhood and juvenile MS
M P Amato, B Goretti, A Ghezzi, et al.
Journal of Neurology
|
February 1, 2023
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a
H Vrenken, M Battaglini, M L de Vos, et al.
Neurology
|
March 12, 2003
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS
M Inglese, J H T M van Waesberghe, M Rovaris, et al.
European Journal of Neurology
|
January 14, 2010
Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort
F Martinelli-Boneschi, F Esposito, D Scalabrini, et al.
Neurology
|
September 30, 2010
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up
M P Amato, B Goretti, A Ghezzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 11, 2010
Psychosocial issue in children and adolescents with multiple sclerosis
B Goretti, A Ghezzi, E Portaccio, et al.
Neurology
|
June 10, 2010
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N De Stefano, A Giorgio, M Battaglini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 16, 2011
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis
S Acaster, P Swinburn, C Wang, et al.
Neurology
|
April 1, 2009
Cognitive and psychosocial features of childhood and juvenile MS
Hadi Hussain, Ahmad Usman, Qasim Raza, et al.
Lancet (London, England)
|
October 10, 2009
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
G Comi, V Martinelli, M Rodegher, et al.
Page
of 59
Search research articles
Search
Showing results (551-560 of 586) with videos related to
Sort By:
Page
of 59
Neurology
|
May 14, 2008
Cognitive and psychosocial features of childhood and juvenile MS
M P Amato, B Goretti, A Ghezzi, et al.
Journal of Neurology
|
February 1, 2023
Temporal evolution of new T1-weighted hypo-intense lesions and central brain atrophy in patients with a first clinical demyelinating event treated with subcutaneous interferon β-1a
H Vrenken, M Battaglini, M L de Vos, et al.
Neurology
|
March 12, 2003
The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS
M Inglese, J H T M van Waesberghe, M Rovaris, et al.
European Journal of Neurology
|
January 14, 2010
Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort
F Martinelli-Boneschi, F Esposito, D Scalabrini, et al.
Neurology
|
September 30, 2010
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up
M P Amato, B Goretti, A Ghezzi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
May 11, 2010
Psychosocial issue in children and adolescents with multiple sclerosis
B Goretti, A Ghezzi, E Portaccio, et al.
Neurology
|
June 10, 2010
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N De Stefano, A Giorgio, M Battaglini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
July 16, 2011
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis
S Acaster, P Swinburn, C Wang, et al.
Neurology
|
April 1, 2009
Cognitive and psychosocial features of childhood and juvenile MS
Hadi Hussain, Ahmad Usman, Qasim Raza, et al.
Lancet (London, England)
|
October 10, 2009
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
G Comi, V Martinelli, M Rodegher, et al.
Page
of 59